Cantitate/Preț
Produs

Medicinal Cannabis and CBD in Mental Healthcare

Autor Kylie O'Brien, Philip Blair
en Limba Engleză Paperback – 28 oct 2021
This book functions as a clinician’s guide to the use of cannabidiol (CBD) in the treatment of mental health conditions. It conveys the scientific evidence of efficacy of CBD as well as THC and addresses the social stigma attached to its medical use.
The book describes the endocannabinoid system, how stress and the endocannabinoid system interact and key constituents, pharmacokinetics and safety aspects of medicinal cannabis, focusing on CBD and THC. Chapters on specific mental health conditions describe the underpinning pathomechanisms including how the endocannabinoid system is involved, and summarises the scientific evidence including animal and human research for the use of CBD and THC in treatment of such conditions. Topics covered include anxiety, depression, post-traumatic stress disorder, insomnia, Alzheimer's Disease and autism spectrum disorder. Chapters also discuss treatment guidelines and case studies.
Unique and focused, Medicinal Cannabis and CBD in Mental Healthcare is an invaluable reference for medical practitioners seeking to adopt CBD-use in their treatment plans.
Citește tot Restrânge

Preț: 56604 lei

Preț vechi: 79183 lei
-29% Nou

Puncte Express: 849

Preț estimativ în valută:
10834 11366$ 8987£

Carte indisponibilă temporar

Doresc să fiu notificat când acest titlu va fi disponibil:

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783030785581
ISBN-10: 3030785580
Pagini: 576
Ilustrații: XXI, 576 p. 1 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.95 kg
Ediția:1st ed. 2021
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland

Cuprins

Introduction.- Endocannabinoid system.- ECS and regulation of stress.- Overview of cannabis.- Stress and Anxiety.-Depression.- PSTD.- Sleep.- Alzheimers.- Autism.- Conclusion.

Notă biografică

Professor Kylie O’Brien PhD
Kylie O’Brien PhD
Adjunct Professor Torrens University
Director of Research & Education
International College of Cannabinoid Medicine

Email: kylie@iccm.co

Phone: +61 412 077689

Dr Philip Blair, MD
Dr. Philip Blair, MD, Colonel (US Army Ret)
CEO of AbleDoc, Inc, International Medical Consultant
Chief Medical Officer, International College of Cannabinoid Medicine
Chief Medical Officer, Releaf Clinics, Australia
Chief Science Officer for Harvest 360
Castle Rock, Washington

email: abledoc@mac.com



Textul de pe ultima copertă

This book functions as a clinician’s guide to the use of cannabidiol (CBD) in the treatment of mental health conditions. It conveys the scientific evidence of efficacy of CBD as well as THC and addresses the social stigma attached to its medical use.
The book describes the endocannabinoid system, how stress and the endocannabinoid system interact and key constituents, pharmacokinetics and safety aspects of medicinal cannabis, focusing on CBD and THC. Chapters on specific mental health conditions describe the underpinning pathomechanisms including how the endocannabinoid system is involved, and summarises the scientific evidence including animal and human research for the use of CBD and THC in treatment of such conditions. Topics covered include anxiety, depression, post-traumatic stress disorder, insomnia, Alzheimer's Disease and autism spectrum disorder. Chapters also discuss treatment guidelines and case studies.
Unique and focused, Medicinal Cannabis and CBD in Mental Healthcare is an invaluable reference for medical practitioners seeking to adopt CBD-use in their treatment plans.

Caracteristici

Unique, focused title on how CBD treatment may be useful in mental health conditions Includes practical algorithms for point of care, clinical use Provides a comprehensive summary of the scientific evidence base for the use of CBD in particular in the treatment of common mental health problems plus guidance on dosing and case studies